Multiparametric 18 F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Lale UmutluJulian KirchnerNils-Martin BruckmannJanna MorawitzGerald AntochSaskia TingAnn-Kathrin BittnerOliver HoffmannLena HäberleEugen RuckhäberleOnofrio Antonio CatalanoMichal ChodylaJohannes GrueneisenHarald H QuickWolfgang P FendlerChristoph RischplerKen HerrmannPeter GibbsPinker KatjaPublished in: Cancers (2022)
F-FDG PET/MRI enables comprehensive high-quality radiomics analysis for the prediction of pCR in breast cancer patients, especially in those with HR+/HER2- receptor status.
Keyphrases
- contrast enhanced
- neoadjuvant chemotherapy
- pet ct
- positron emission tomography
- computed tomography
- pet imaging
- magnetic resonance imaging
- locally advanced
- diffusion weighted imaging
- magnetic resonance
- lymph node
- sentinel lymph node
- lymph node metastasis
- squamous cell carcinoma
- radiation therapy
- early stage
- binding protein